Stockscreener 앱 받기
122.41
5.64%
6.53
시간 외 거래:
122.50
0.09
+0.07%
Merck Co Inc 주식(MRK)의 최신 뉴스
LSV Asset Management Cuts Stake in Merck & Co., Inc. $MRK - MarketBeat
Legato Capital Management LLC Buys 8,759 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. stock (US58933Y1055): oncology momentum and fresh debt deal move MRK - AD HOC NEWS
A Look at Merck & Co Inc (MRK) After 5.6% Gain -- GF Value $118.14 vs Price $122.41 - GuruFocus
Research Alert: CFRA Raises Opinion On Shares Of Merck & Co., Inc. To Strong Buy From Buy - Moomoo
S&P 500 Rally Defies Weak Sentiment and Hawkish Fed Signals - Investing.com
AbbVie, Merck, Astra among winners of EU drug recommendations this week - Seeking Alpha
Merck & Co Inc Stock (MRK) Opened Up by 4.50% on May 22: Facts Behind the Movement - TradingKey
Merck & Co., Inc. stock (US58933Y1055): Key cancer drug data and dividend profile in focus - AD HOC NEWS
Merck and Kelun's lung cancer combo bests Keytruda in late-stage trial - Seeking Alpha
Keudell Morrison Wealth Management Invests $1.33 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Pinnbrook Capital Management LP - MarketBeat
Axxcess Wealth Management LLC Buys 263,633 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Merck and Ecolab lead M&A funding charge - GlobalCapital
Moderna, Merck cancer combo cuts melanoma spread risk at five years - Reuters
All Merck Articles - 24/7 Wall St.
Merck & Co., Inc. stock (US58933Y1055): cancer franchise drives outlook after latest Keytruda data - AD HOC NEWS
44 WEALTH MANAGEMENT LLC's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co. Inc. stock (US58933Y1055): Keytruda data and Q1 2026 results keep pharma heavyweight in - AD HOC NEWS
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Merck & Co. Inc. stock (US58933Y1055): Key takeaways from the latest Keytruda growth and pipeline up - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): Key takeaways after latest Keytruda data and Q1 earnings - AD HOC NEWS
Cullen Frost Bankers Inc. Has $22.74 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock (US58933Y1055): Key takeaways after latest Keytruda data and oncology updates - AD HOC NEWS
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Merck & Co., Inc. stock (US58933Y1055): Key takeaways after the latest Keytruda and Gardasil updates - AD HOC NEWS
VANGUARD ADVICE SELECT GLOBAL VALUE FUND's Merck & Co Inc(MRK) Holding History - GuruFocus
Handelsbanken Fonder AB Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Gabelli Funds LLC Cuts Holdings in Merck & Co., Inc. $MRK - MarketBeat
HighTower Advisors LLC Sells 50,990 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Trade Ideas — LSX:A0YD8Q - TradingView
Merck & Co. Inc. stock (US58933Y1055): Terns deal, oncology pipeline keep focus on growth - AD HOC NEWS
Results Reinforce Merck/Kelun’s Sac-TMT As Major TROP2 Player - Citeline News & Insights
Merck & Co. Inc. stock (US58933Y1055): oncology growth meets new M&A financing - AD HOC NEWS
Merck's drug helps uterine cancer patients live longer in late-stage trial - Reuters
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer - Business Wire
Merck & Company, Inc. (MRK) Stock Analysis: A Healthcare Giant with a Robust 3.05% Dividend Yield - DirectorsTalk Interviews
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Merck & Co., Inc. (MRK) is attracting investor attention: Here is what you should know - MSN
L & S Advisors Inc Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Canada Post Corp Registered Pension Plan Acquires 35,631 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. stock (US58933Y1055): Keytruda momentum and fresh earnings keep big pharma in focu - AD HOC NEWS
Financial Security Advisor Inc. Raises Holdings in Merck & Co., Inc. $MRK - MarketBeat
Lockheed Martin Investment Management Co. Has $9.87 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Convergence Investment Partners LLC - MarketBeat
Merck & Co., Inc. $MRK Stake Reduced by ANTIPODES PARTNERS Ltd - MarketBeat
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck & Co. Inc. stock (US58933Y1055): Key cancer franchise drives fresh earnings spotlight - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): pharma giant doubles down on M&A as investors eye post-Keytr - AD HOC NEWS
Thrivent Financial for Lutherans Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK is Conning Inc.'s 5th Largest Position - MarketBeat
Bessemer Group Inc. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Allworth Financial LP Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
MRK News | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Mondrian Global Equity Value Fund's Merck & Co Inc(MRK) Holding History - GuruFocus
Horizon Dividend Income ETF's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co., Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Merck & Co. Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
World Investment Advisors Buys 20,067 Shares of Merck & Co., Inc. $MRK - MarketBeat
Rayburn West Financial Services LLC Takes $1.17 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Summit Wealth Group LLC Co. Has $522,000 Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Buys 100,280 Shares of Merck & Co., Inc. $MRK - MarketBeat
Top Companies in Hospital Acquired Infection Treatment MarketMerck & Co Inc, Pfizer Inc, Cipla Ltd etc. - openPR.com
Merck & Co. Inc. stock (US58933Y1055): Q1 results show revenue growth amid Keytruda strength - AD HOC NEWS
1.43%
0.16%
자본화:
|
볼륨(24시간):